Clinical Trial Update: Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of BGG492 on EEG in patients with photosensitive epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy

Drugs mentioned

• BGG492

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Photosensitive Epilepsy | Phase 2 | Status: COMPLETED